VICTORIA WEBBER: Open Payments
NPI 1851066690 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,147 in 83 payments from 26 companies in 2025. Trend: 2023 $1,167 · 2024 $1,630 · 2025 $2,147
Food & beverage: $2,047Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $389 |
| Sumitomo Pharma America, Inc. | 8 | $203 |
| Endo USA, Inc. | 7 | $184 |
| TOLMAR, INC. | 10 | $179 |
| IMMUNITYBIO, INC. | 6 | $164 |
| Ferring Pharmaceuticals Inc. | 7 | $142 |
| Dendreon Pharmaceuticals LLC | 5 | $98 |
| UROGEN PHARMA, INC. | 2 | $75 |
| Astellas Pharma US Inc | 3 | $74 |
| Telix Pharmaceuticals | 3 | $58 |
Products named: ERLEADA, GEMTESA, ANKTIVA, ADSTILADRIN, JATENZO, PROVENGE, AVEED, XIAFLEX.
Industry payments across RI — which companies pay providers there.
